Bill118th CongressFiled Mar 17, 2023Health
H.R. 1613
Drug Price Transparency in Medicaid Act of 2023
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it does
A plain-language summary from the Congressional Research Service isn’t available yet for this bill. CRS summaries are typically posted within a few weeks of introduction.
What just happenedMar 24, 2023
Referred to the Subcommittee on Health.
Who’s behind it
Rep. Carter, Earl L. "Buddy" [R-GA-1](R-GA)Sponsor
37 cosponsors14 D23 R
37cosponsors1committees4actions2related bills12subjects
- Introduced in HouseMar 17, 2023
- Mar 24, 2023Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Mar 17, 2023IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Mar 17, 2023IntroReferralIntro-H
Introduced in House
- Mar 17, 2023IntroReferral1000
Introduced in House